Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

Published:2022-02 Issue:2 Volume:10 Page:102-111
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Fleseriu Maria,Dreval Alexander,Bondar Irina,Vagapova Gulnar,Macut Djuro,Pokramovich Yulia G,Molitch Mark E,Leonova Nina,Raverot Gerald,Grineva Elena,Poteshkin Yury E,Gilgun-Sherki Yossi,Ludlam William H,Patou Gary,Haviv Asi,Gordon Murray B,Biermasz Nienke R,Melmed Shlomo,Strasburger Christian J

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Multidisciplinary management of acromegaly: a consensus;Giustina;Rev Endocr Metab Disord,2020

2. Pituitary-tumor endocrinopathies;Melmed;New Eng J Med,2020

3. A Pituitary Society update to acromegaly management guidelines;Fleseriu;Pituitary,2021

4. The burden of disease for pituitary patients;Biermasz;Best Pract Res Clin Endocrinol Metab,2019

5. Improvement in symptoms and health-related quality of life in acromegaly patients: a systematic review and meta-analysis;Broersen;J Clin Endocrinol Metab,2021

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and Function of Somatostatin and Its Receptors in Endocrinology;Endocrine Reviews;2024-08-08

2. Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Treatment of acromegaly with oral octreotide;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

4. Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use;Expert Review of Endocrinology & Metabolism;2024-06-06

5. Medical treatment of functional pituitary adenomas, trials and tribulations;Journal of Neuro-Oncology;2024-05-18